Ramiro Sanchez Insider Trades & Stock Holdings

Director · Rapport Therapeutics, Inc. · Latest filing Oct 23, 2026

Ramiro Sanchez, Director at Rapport Therapeutics, Inc. has 1 Form 4 trade on file since Oct 23, 2026. Open-market activity: 1 purchase ($98.48K) and 0 sales ($0), net +$98.48K. Latest filing: acquired 3.60K shares of $RAPP on Oct 23, 2026 at $27.35.

Trades on file
1
Open-market bought
$98.48K
Open-market sold
$0
Net open-market
+$98.48K
Shares held ($RAPP)
3.60K
Latest filing
Oct 23, 2026

Shares held by Ramiro Sanchez

Shares owned after the most recent Form 4 for each company.

All insider trades by Ramiro Sanchez

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$RAPP Buy (Open-market buy) 3.60K $27.35 $98.48K 3.60K Director SEC Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Ramiro Sanchez traded

Frequently asked questions

Has Ramiro Sanchez been buying or selling stock?

Ramiro Sanchez has 1 open-market purchase and 0 open-market sales on file, net +$98.48K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Ramiro Sanchez's latest insider trade?

acquired 3.60K shares of $RAPP on Oct 23, 2026 at $27.35.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions